Get the Stockscreener App
3.64
3.96%
-0.15
After Hours:
3.64
Genelux Corp stock is traded at $3.64, with a volume of 58,895.
It is down -3.96% in the last 24 hours and up +8.98% over the past month.
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
See More
Previous Close:
$3.79
Open:
$3.79
24h Volume:
58,895
Relative Volume:
0.47
Market Cap:
$137.50M
Revenue:
-
Net Income/Loss:
$-27.66M
P/E Ratio:
-3.8316
EPS:
-0.95
Net Cash Flow:
$-24.36M
1W Performance:
+8.33%
1M Performance:
+8.98%
6M Performance:
-15.55%
1Y Performance:
+74.16%
1-Day Range:
$3.64
$3.85
1-Week Range:
$3.31
$4.0697
52-Week Range:
$1.95
$5.885
Genelux Corp Stock (GNLX) Company Profile
Name
Genelux Corp
Sector
Industry
Phone
805-267-9889
Address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Compare GNLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNLX
Genelux Corp
|
3.64 | 143.16M | 0 | -27.66M | -24.36M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Genelux Corp Stock (GNLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-29-24 | Initiated | Guggenheim | Buy |
| Aug-28-24 | Initiated | ROTH MKM | Buy |
| Nov-27-23 | Initiated | H.C. Wainwright | Buy |
| Sep-12-23 | Initiated | Maxim Group | Buy |
| Feb-15-23 | Initiated | The Benchmark Company | Speculative Buy |
Genelux Corp Stock (GNLX) Latest News
Using Bollinger Bands to evaluate Genelux CorporationPortfolio Return Report & Long-Term Growth Plans - Newser
Is now a turning point for Genelux CorporationJuly 2025 Opening Moves & Community Verified Watchlist Alerts - Newser
Has Genelux Corporation found a price floorMarket Growth Review & Capital Protection Trading Alerts - Newser
Is a relief rally coming for Genelux Corporation holdersJuly 2025 Pullbacks & High Accuracy Investment Signals - Newser
Applying Wyckoff theory to Genelux Corporation stockQuarterly Portfolio Review & Fast Gaining Stock Reports - Newser
Technical signs of recovery in Genelux CorporationMarket Risk Report & Fast Gain Stock Trading Tips - Newser
Does Genelux Corporation show high probability of rebound2025 Key Lessons & Real-Time Buy Zone Alerts - Newser
Genelux Corporation (NASDAQ:GNLX) Receives $17.75 Average PT from Analysts - Defense World
Is Genelux Corporation showing signs of accumulation2025 Price Momentum & AI Based Trade Execution Alerts - Newser
Genelux Corporation (NASDAQ:GNLX) Receives Average Rating of “Buy” from Analysts - Defense World
What recovery options are there for Genelux CorporationLong Setup & Fast Momentum Entry Tips - Newser
Published on: 2025-08-19 11:24:03 - 선데이타임즈
Why Genelux Corporation stock attracts strong analyst attentionDollar Strength & Weekly Chart Analysis and Trade Guides - classian.co.kr
Genelux Corporation stock prediction for this weekLayoff News & Verified Momentum Stock Alerts - Newser
Can trapped investors hope for a rebound in Genelux CorporationMarket Volume Report & Long-Term Investment Growth Plans - Newser
How sentiment analysis helps forecast Genelux CorporationQuarterly Trade Review & Safe Capital Investment Plans - Newser
Heatmap analysis for Genelux Corporation and competitorsQuarterly Trade Review & Community Consensus Trade Alerts - Newser
Genelux Corporation stock trend forecastQuarterly Market Review & Community Consensus Trade Signals - Newser
Brookline Capital Management Estimates Genelux Q3 Earnings - Defense World
Genelux Corporation stock daily chart insightsMarket Weekly Review & Weekly High Return Forecasts - Newser
Using AI based signals to follow Genelux CorporationQuarterly Growth Report & Detailed Earnings Play Alerts - Newser
News impact scoring models applied to Genelux CorporationPortfolio Risk Summary & Free Growth Oriented Trading Recommendations - Newser
What are the risks of holding Genelux CorporationOil Prices & AI Powered Market Trend Analysis - mustnews.co.kr
Building trade automation scripts for Genelux CorporationJuly 2025 Institutional & Verified Trade Idea Suggestions - Newser
Genelux Corporation Stock Support and Resistance Levels You Should KnowJuly 2025 Decliners & High Conviction Buy Zone Picks - Newser
Technical analysis overview for Genelux Corporation stockWeekly Trade Report & Community Shared Stock Ideas - Newser
How Efficient Is Genelux Corporation at Controlling Operating Costs [July 2025 Analyst Calls]Smart Investment Allocation Tips - Newser
Genelux Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Genelux Corp.’s Innovative Cancer Treatment Approach Earns Buy Rating - TipRanks
What to do if you’re stuck in Genelux CorporationFree Community Entry Consensus Trade Ideas - Newser
Advanced analytics toolkit walkthrough for Genelux CorporationWeekly Gain Forecast with Momentum Indicators - Newser
How to escape a deep drawdown in Genelux CorporationIntraday Signal Forecast for Fast Traders - Newser
Promising Outlook for Genelux Corp. with Olvi-Vec Advancements and Strong Financial Position - TipRanks
Genelux Corp.'s Olvi-Vec: A Promising Oncology Treatment with a Buy Rating - AInvest
Genelux Corp Stock (GNLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):